MIAMI (PRWEB) October 13, 2014 Regenestem, one of the largest membership networks of regenerative medicine clinics worldwide, has announced the launch of a new stem cells clinic in Antofagasta, Northern Chile. The clinic, to be headed by renowned stem cell specialists DRA Maria G. Soledad Gonzalez and Angel Gallegos Freire, M.D., will provide the latest advancements in stem cell treatments and protocol for a variety of eye conditions and diseases including macular degeneration and retinitis pigmentosa, as well as the latest anti-aging and aesthetic treatments and therapies. Soledad Gonzalez specializes in opthamology at the Laser Surgery Clinic in Higher Vision of Antofagasta since 2003, where he focuses on refractive surgery to treat conditions like myopia, hyperopia, astigmatism and presbyopia. He incorporated minimally invasive aesthetic medicine protocols to his practice in 2012 and specializes in the harvest, preparation, activation and application of stem cell therapies for a number of chronic degenerative diseases. Gallegos Freire, Medical Director, Policlinico Bhpbilliton M: BHP Billiton Spencea in Ubicacin, Chile, specializing in aesthetic and anti-aging stem cell medicine. Gallegos Freire in an active member of the Argentina Society of Aesthetic Medicine (SOARME), Institutional Member of the Medical Association of Argentina (AMA), the Pan-American Society of Aesthetic … Continue reading →

Beverly Hills, California (PRWEB) October 13, 2014 Top Beverly Hills and LA orthopedic doctor, Dr. Raj, is now offering platelet rich plasma therapy for sports injuries and all types of degenerative arthritis. The treatment option has recently been added to Dr. Raj's regenerative medicine therapies such as bone marrow derived stem cell procedures and amniotic derived stem cell therapies. Call (310) 247-0466 for more information and scheduling. Platelet Rich Plasma Therapy, known as PRP for short, has been increasing in popularity due to the success shown in several research studies. There was a recent study out of HSS showing amazing outcomes for degenerative knee arthritis, with preservation of cartilage and significant pain relief. Results with rotator cuff tendonitis, tennis elbow, plantar fasciitis and knee/achilles tendonitis have also been excellent as well. Athletes in all types of sports have benefited from PRP therapy including golf, tennis, basketball, football, baseball and more. Whether or not an athlete is professional or amateur, the PRP treatment can be instrumental in helping patients avoid surgery and get back on the field quickly. PRP therapy at Beverly Hills Orthopedic Institute involves an outpatient procedure that begins with a simple blood draw from the patient's arm of … Continue reading →

PBR Staff Writer Published 13 October 2014 UK-based Hikma Pharmaceuticals has entered into a five-year partnership to distribute Eisais first-in-class epilepsy treatment, Fycompa (perampanel), in the Middle East. Perampanel is used as an adjunctive treatment of partial onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older. The partnership will start immediately, with perampanel launches throughout the region expected to follow in 2015. Hikma Pharmaceutical executive vice chairman, president and CEO of MENA and Emerging Markets Mazen Darwazah said, "We are committed to our partnership with Eisai, which supports our strategy of working with global partners to strengthen our product portfolio in growing therapeutic areas and to bring important treatment options to patients in the Middle East region." Countries covered by the partnership will include the Kingdom of Saudi Arabia, the UAE, Jordan, Kuwait, Bahrain, Oman, Qatar, Sudan, Iraq, Libya and Yemen. Perampanel is the only licensed anti-epileptic drug (AED) designed to selectively target AMPA receptors, a protein in the brain which plays a major role in the spread of seizures. Additionally, perampanel has the added benefit of convenient, once-daily dosing at bedtime.i Read this article: Hikma to distribute Eisai's epilepsy treatment Fycompa … Continue reading →

The results of a new autism study were so surprising even one of the authors called it far- fetched, at least on the surface. If you tell someone youre treating autism with broccoli, they would think you are off your rocker, said Paul Talalay, who is head of the Laboratory for Molecular Pharmacology at Johns Hopkins University. He and his collaborators announced today that when they gave a compound called sulforaphane, derived from broccoli, to a small group of severely to moderately autistic teenage boys and young men, there was a dramatic improvement in the subjects symptoms. They were calmer, more social and in some cases, more verbal. This experiment was no long shot, however. It grew out of a long history involving the intersection of two well-developed courses of research. Coming at it from one side was Talalay, who had been following his curiosity about cancer prevention and vegetables. From another angle came pediatric neurologist Andrew Zimmerman, who had been fascinated by anecdotal reports from parents that their autistic children improved during bouts of fever. English: Broccoli Deutsch: Broccoli (Photo credit: Wikipedia) The study was small, involving just 29 patients who got the compound and 15 on a placebo. … Continue reading →

PUBLIC RELEASE DATE: 13-Oct-2014 Contact: Cassandra Aviles cmaviles@partners.org 617-724-6433 Massachusetts General Hospital @MassGeneralNews A small study led by investigators at MassGeneral Hospital for Children (MGHfC) and Johns Hopkins University School of Medicine has found evidence that daily treatment with sulforaphane a molecule found in foods such as broccoli, cauliflower and cabbage may improve some symptoms of autism spectrum disorders. In their report being published online in PNAS Early Edition, the investigators describe how participants receiving a daily dose of sulforaphane showed improvement in both behavioral and communication assessments in as little as four weeks. The authors stress that the results of this pilot study conducted at the MGHfC-affiliated Lurie Center for Autism must be confirmed in larger investigations before any conclusions can be drawn about sulforaphane's therapeutic benefit. "Over the years there have been several anecdotal reports that children with autism can have improvements in social interaction and sometimes language skills when they have a fever," explains Andrew Zimmerman, MD, a co-corresponding author of the current report who also published a 2007 paper documenting the fever effect. "We investigated what might be behind that on a cellular level and postulated that it results from fever's activation of the cellular stress … Continue reading →